WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 72, Issue 6, Pages 1688-1695
Publisher
Oxford University Press (OUP)
Online
2017-01-30
DOI
10.1093/jac/dkx035
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro activity of cefepime/zidebactam (WCK 5222) against Gram-negative bacteria
- (2017) David M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Structural and Kinetic Characterization of Diazabicyclooctanes as Dual Inhibitors of Both Serine-β-Lactamases and Penicillin-Binding Proteins
- (2016) Andrew M. King et al. ACS Chemical Biology
- A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens
- (2015) Karen Bush INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam ‘enhancer’
- (2015) Akihiro Morinaka et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular Epidemiology and Mechanisms of Carbapenem Resistance ofAcinetobacterspp. in Asia and Oceania
- (2015) Witchuda Kamolvit et al. Microbial Drug Resistance
- The β-Lactams Strike Back: Ceftazidime-Avibactam
- (2015) Evan J. Zasowski et al. PHARMACOTHERAPY
- Carbapenemase-Producing Enterobacteriaceae
- (2015) David Paterson et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- New β-Lactamase Inhibitors: a Therapeutic Renaissance in an MDR World
- (2013) Sarah M. Drawz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance
- (2013) Alan P. Johnson et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
- (2013) L Silvia Munoz-Price et al. LANCET INFECTIOUS DISEASES
- OXA-48-like carbapenemases: the phantom menace
- (2012) L. Poirel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae
- (2011) Z. Aktaş et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-ProducingEnterobacteriaceae
- (2010) David M. Livermore et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK
- (2009) M. Doumith et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Global spread of carbapenem-resistant Acinetobacter baumannii
- (2009) P. G. Higgins et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search